RNAM - Avidity Biosciences, Inc.
72.82
0.020 0.027%
Share volume: 16,757,238
Last Updated: 02-26-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.15%
PREVIOUS CLOSE
CHG
CHG%
$72.80
0.02
0.00%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-09-2024 | 11-07-2024 | 02-27-2025 | 05-08-2025 | 11-10-2025 | 02-23-2026 | |
| Cash flow financing | 389.445 M | 446.724 M | 342.464 M | 13.724 M | 1.937 M | 850.366 M | -5.086 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -70.380 M | 106.851 M | -205.564 M | -150.319 M | 34.296 M | 106.267 M | 32.359 M | |
| Net income | -68.855 M | -70.793 M | -80.398 M | -102.256 M | -115.773 M | -174.442 M | -237.101 M | |
| Depreciation | 641.000 K | 687.000 K | 710.000 K | 738.000 K | 785.000 K | 1.056 M | 1.496 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -32.747 M | -274.869 M | -482.413 M | -64.172 M | 157.188 M | -587.926 M | 207.218 M | |
| Net Borrowings | -925.327 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | -891.000 K | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -915.000 K | 531.000 K | 1.704 M | 3.916 M | 3.753 M | 712.000 K | 5.511 M | |
| Cash Change | 915.873 M | 106.851 M | -205.564 M | -150.319 M | 34.335 M | 106.251 M | 32.358 M |